Anidulafungin treatment in a kidney transplant recipient with hepatic damage

Francesco G De Rosa; N A Manzione; Andrea Ranghino; Marina Messina; Antonio Ottobrelli; Stefania Raviolo; Giovanni Di Perri; Giuseppe Paolo Segoloni

doi:10.1111/j.1439-0507.2011.02137.x

Anidulafungin treatment in a kidney transplant recipient with hepatic damage

Mycoses. 2011 Dec:54 Suppl 4:12-5. doi: 10.1111/j.1439-0507.2011.02137.x.

Authors

Francesco G De Rosa¹, N A Manzione, Andrea Ranghino, Marina Messina, Antonio Ottobrelli, Stefania Raviolo, Giovanni Di Perri, Giuseppe Paolo Segoloni

Affiliation

¹ Infectious Diseases Department, Ospedale Amedeo di Savoia, University of Turin, Italy. francescogiuseppe.derosa@unito.it

PMID: 22126524
DOI: 10.1111/j.1439-0507.2011.02137.x

Abstract

A 50-year old female was treated with anidulafungin after fluconazole treatment, for a complex clinical picture and immunosuppression. Anidulafungin was chosen when liver function test was abnormal in a setting of multiple causes of liver toxicity.

Publication types

Case Reports

MeSH terms

Anidulafungin
Antifungal Agents / administration & dosage*
Antifungal Agents / adverse effects*
Chemical and Drug Induced Liver Injury*
Echinocandins / administration & dosage*
Female
Fluconazole / administration & dosage
Fluconazole / adverse effects*
Humans
Immunocompromised Host
Immunosuppressive Agents / administration & dosage
Immunosuppressive Agents / adverse effects*
Kidney Transplantation / adverse effects
Middle Aged
Transplantation

Substances

Antifungal Agents
Echinocandins
Immunosuppressive Agents
Fluconazole
Anidulafungin